Additional file 1 of Neoadjuvant docetaxel and capecitabine (TX) versus docetaxel and epirubicin (TE) for locally advanced or early her2-negative breast cancer: an open-label, randomized, multi-center, phase II Trial
| Autor: | Yang, Houpu, Xu, Ling, Guan, Shan, Hao, Xiaopeng, Ge, Zhicheng, Tong, Fuzhong, Cao, Yingming, Liu, Peng, Zhou, Bo, Cheng, Lin, Liu, Miao, Liu, Hongjun, Xie, Fei, Wang, Siyuan, Peng, Yuan, Wang, Chaobin, Wang, Shu |
|---|---|
| Rok vydání: | 2023 |
| DOI: | 10.6084/m9.figshare.22598795.v1 |
| Popis: | Additional file 1. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|